{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259159436", "close" : "1259182836", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
businesswire

Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Allion Healthcare, Inc.


  • Press Release
  • Source: Brodsky & Smith, LLC
  • On 4:44 pm EDT, Wednesday October 21, 2009

BALA CYNWYD, Pa.--(BUSINESS WIRE)--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Allion Healthcare, Inc. (“Allion” or the “Company”) (Nasdaq:ALLI - News) relating to the proposed acquisition by H.I.G. Capital, Inc., (“H.I.G.”).

Related Quotes

SymbolPriceChange
ALLI6.500.00
Chart for Allion Healthcare, Inc.
{"s" : "alli","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Under the proposed agreement, Allion shareholders will receive $6.60 for every share of Allion common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the Allion board’s approval of the proposed merger. The transaction appears to be unfair, in part, given that Allion stock was trading at $7.02 a share as recently as September 10, 2009 and $7.40 a share on July 31, 2009.

If you own shares of Allion and wish to discuss the legal ramifications of the proposed acquisition by H.I.G., or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.

Contact:

Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
877-LEGAL-90
clients@brodsky-smith.com

Sponsored Links

Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.